Knowledge that can improve identification and risk stratification of a heart disorder that can cause sudden cardiac death
Scientists at deCODE genetics, a subsidiary of Amgen, in collaboration with researchers at the National University Hospital of Iceland, have published a study on a cardiac electrical abnormality that can potentially result in sudden cardiac death.
First genetic locus for voice pitch
A study from deCODE genetics reveals the first genetic locus for voice pitch.
Introducing Human Data Era, a New Serial Podcast from Amgen
Join host Ray Deshaies, Amgen’s senior vice president of Global Research, who speaks with dr Kári Stefánsson, M.D., founder, of deCODE genetics about the Role of Human Diversity in Progressing Precision Medicine.
Multiomics study of nonalcoholic fatty liver disease
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD).
UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.